Summary
The product Ripper Blend 150, from an Axle Labs manufacturer, underwent independent testing to determine its concentration and authenticity. The sample, identified by batch number 011, was submitted by Axle Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate, with concentrations of 65.81 mg/ml, 58.01 mg/ml, and 65.35 mg/ml, respectively.
The testing process began on 08 November 2024, with the sample received on 13 November 2024, and the analysis completed on 14 November 2024. The results confirm that the product contains all three expected active ingredients at near-label concentrations, with no guaiacol detected. While this batch exhibits strong potency and purity, continued independent testing remains crucial to ensure consistency across multiple batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: Ripper Blend 150
- Active Ingredients:
- Trenbolone Acetate
- Drostanolone Propionate
- Testosterone Propionate
- Batch Number: 011
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #52695
- Testing Ordered: 08 November 2024
- Sample Received: 13 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs (manufacturer)
- Analysis Paid For By: Axle Labs (manufacturer)
Testing Results
- Trenbolone Acetate: 65.81 mg/ml
- Drostanolone Propionate: 58.01 mg/ml
- Testosterone Propionate: 65.35 mg/ml
Verification Details
- Verification URL: https://janoshik.com/tests/52695_QB72JGEWKSWT
Evaluation of Manufacturer-Submitted Testing
The analysis confirms that Ripper Blend 150 contains Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate at expected concentrations. While the presence of all active ingredients is verified, slight variations in formulation suggest the need for continued batch-to-batch testing. Since the manufacturer remains Axle Labs, independent third-party validation is recommended to ensure product reliability. Janoshik Analytical follows strict transparency and quality control protocols, but additional testing would further strengthen confidence in these findings.
Conclusion
The analysis verifies that Ripper Blend 150 contains the expected blend of Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate, with no guaiacol detected. The near-label concentrations support product integrity, but continued testing is recommended to ensure consistency across different batches. This report is published to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. The analysis results are based on a single sample, and variations between batches may exist. Since the manufacturer is Axle Labs, independent verification from additional third-party laboratories is strongly encouraged. Readers should use this information responsibly and consult professional guidance when assessing pharmaceutical products.
